Propanc Biopharma Announces Positive Preclinical and Early Translational Data for PRP Showing >90% Tumor Growth Inhibition and Significant Survival Benefit in Pancreatic Ductal Adenocarcinoma Models

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/21/2026

1. SPY
2. ACN
3. FFAI
4. PAGP
5. WBD
6. FAN
7. COHR
8. NXE
9. STI
10. MCD

Go back to Propanc Biopharma Announces Positive Preclinical and Early Translational Data for PRP Showing >90% Tumor Growth Inhibition and Significant Survival Benefit in Pancreatic Ductal Adenocarcinoma Models
(NASDAQ: PPCB) Delayed: 0.61 --0 (-0%)
Previous Close $0.61    52 Week High $ 
Open $0.61    52 Week Low $ 
Day High $0.61    P/E N/A 
Day Low $0.61    EPS $ 
Volume 8,164       

(NASDAQ: PPCB) Delayed: 0.61 --0 (-0%)
Previous Close $0.61    52 Week High $ 
Open $0.61    52 Week Low $ 
Day High $0.61    P/E N/A 
Day Low $0.61    EPS $ 
Volume 8,164